Frederick National Laboratory for Cancer Research

Home
United States
Frederick, MD
Frederick National Laboratory for Cancer Research

Leidos Biomed operates the Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute.

Leidos Biomed operates the Frederick National Laboratory for Cancer Research, a U.S. national lab focused on discovery and innovation in biomedical science and rapid response to emerging infectious diseases. Sponsored by the National Cancer Institute, the laboratory collaborates with public and private partners to solve urgent and intractable problems in biomedical science. We conduct investigator-initiated, hypothesis-driven research -- with a focus on cancer and AIDS -- and maintain an integrated suite of leading-edge biomedical technologies as shared national resources. Our scientific expertise is broad and deep, covering genetics, genomics, protein science, proteomics, bioinformatics, immunology, high-performance biomedical computing, nanotechnology, biopharmaceutical manufacturing, laboratory animal sciences, and clinical operations. The Frederick National Lab is headquartered in Frederick, Md., 50 miles north of Washington, D.C.

11/20/2025

The Frederick National Laboratory for Cancer Research meets the nation's most urgent biomedical research needs and serves as a national and global resource for the scientific community. Our scientists conduct basic, translational, and applied research, develop new technologies, and collaborate with government, industry, and academic colleagues: https://frederick.cancer.gov/about

09/02/2025

The Frederick National Laboratory continues to make impactful contributions to lung through scientific discoveries and collaborations that are shaping the future of cancer treatment. Explore our recent discoveries:

⭐️ RAS drug discovery at FNL reaches lung cancer patients in a clinical trial: https://heyor.ca/gCf1up

⭐️ Controlling blood sugar may improve outcomes for diabetic lung cancer patients: https://heyor.ca/fMHOzH

⭐️ CDK2 inhibition may have potential for treating lung and other cancers: https://heyor.ca/W2fpbC

An investigational treatment co-discovered by RAS Initiative scientists at the Frederick National Laboratory (FNL) is now being tested in patients with advanced non-small cell lung cancer driven by mutant KRAS G12C.

08/06/2025

We had a great time at the Frederick County Chamber of Commerce’s kickoff to yesterday, celebrating the power of momentum! The event was truly inspiring – a day filled with meaningful connections, empowerment, and personal growth as we honored the remarkable women driving change in our community and beyond.

07/16/2025

🌶️ It’s growing season, and many employees in our Cancer Research Technology Program head home from the lab to tend to their chili pepper plants. They trade seeds, share seedlings, and in the fall, gather for a chili pod tasting. Even non-gardeners get to join the fun, enjoying recipes and homemade hot sauces.

While cancer research and pepper cultivation don’t exactly go hand in hand, these scientists still flex their skills. Whether it’s sowing seeds, breeding new variations, controlling pests or making hot sauce, there are countless opportunities to hone scientific skills and optimize pepper growth.

Address

8560 Progress Drive
Frederick, MD
21701

Telephone

+13018461000

Website

http://frederick.cancer.gov/

Alerts

Be the first to know and let us send you an email when Frederick National Laboratory for Cancer Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Frederick?

Our Story

The Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, is a U.S. national laboratory focused on discovery and innovation in biomedical science and rapid response to emerging infectious diseases. Sponsored by the National Cancer Institute, the laboratory collaborates with public and private partners to solve urgent and intractable problems in biomedical science. We conduct investigator-initiated, hypothesis-driven research -- with a focus on cancer and AIDS -- and maintain an integrated suite of leading-edge biomedical technologies as shared national resources. Our scientific expertise is broad and deep, covering genetics, genomics, protein science, proteomics, bioinformatics, immunology, high-performance biomedical computing, nanotechnology, biopharmaceutical manufacturing, laboratory animal sciences, and clinical operations. The Frederick National Laboratory is headquartered in Frederick, Md., 50 miles north of Washington, D.C.